Corneal Ulcer clinical trials

The registry lists 63 studies for Corneal Ulcer across more than 10 countries. 8 are recruiting or about to start. 54 of them are mainly about Corneal Ulcer (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04.

Get an email when these change. Save the Corneal Ulcer studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 33
Status unknown: 12
Withdrawn: 5
Recruiting: 5
Terminated: 4
Not yet recruiting: 3

Phase

Phase 2: 14
Phase 3: 9
Phase 1: 6
Phase 4: 3
Early Phase 1: 2

Where

United States: 22
India: 11
Egypt: 8
France: 5
China: 5
Taiwan: 4

Who runs them

University of California, San Francisco (6) · Minia University (3) · Aravind Eye Care System (2) · TBF Genie Tissulaire (2) · Peschke GmbH (2) · Dompé Farmaceutici S.p.A (2) · National Taiwan University Hospital (2) · Hospital Risoleta Tolentino Neves (1)

What is being tested here

Drugs under test in Corneal Ulcer studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Topical Corticosteroid	1	1	2
Fluorometholone	1	0	1
Cyclosporine	1	1	1
Riboflavin	0	0	2
Voriconazole	0	2	2
Recombinant human nerve growth factor	0	0	1
Naltrexone	0	0	1
Carboxymethylcellulose	0	0	1
Platelet rich plasma	0	0	1
Povidone-Iodine	0	0	1

Coming up

2phase 3 studies under way

3studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3, phase 3 first

Sep 2027Fungal Ulcer Treatment Augmented With Natamycin and Cyclosporine A · Phase 3 · University of California, San Francisco
Dec 2026Efficacy of Locally Delivered Allogeneic Mesenchymal Stromal Cells · University of Illinois Chicago
Jun 2027Follow-up Compliance for Corneal Ulcer Patients With SMS Reminder · Seva Canada Society

Who these studies take

Of the 5 Corneal Ulcer studies recruiting now, 4 (80%) set no upper age limit and 1 (20%) stop at 75 or younger. 1 (20%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	1 (20%)	1 (20%)
18	4 (80%)	4 (80%)
30	5 (100%)	5 (100%)
40	5 (100%)	5 (100%)
50	5 (100%)	5 (100%)
65	5 (100%)	5 (100%)
75	4 (80%)	4 (80%)
85	4 (80%)	4 (80%)

Across all 63 studies, recruiting or not: 14% stop at 75 or younger and 6% at 65; 30% take children; 0% are for women only and 0% for men only; 6% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 50 of 63. Browse all 63 → or search them.